- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
ANMR replaces Lynch as MDI chief
Advanced NMR announced last month that it has fired John Lynch,the president of Medical Diagnostics, a mobile MRI firm that ANMRacquired in August (SCAN 9/13/95). Advanced NMR, of Wilmington, MA, declined to state the reasonsfor Lynch's departure. As
Advanced NMR announced last month that it has fired John Lynch,the president of Medical Diagnostics, a mobile MRI firm that ANMRacquired in August (SCAN 9/13/95).
Advanced NMR, of Wilmington, MA, declined to state the reasonsfor Lynch's departure. As MDI president, Lynch had sought outAdvanced NMR as a white knight to rescue the company from a hostiletakeover launched by Raytel Medical late last year (SCAN 12/14/94).
ANMR said it has replaced Lynch with David Gaynor as actingpresident. Gaynor has overseen MDI's operations as COO since 1988,the company said.
New Study Assesses Long-Term Outcomes of PSMA PET Use in PCa Recurrence Cases
October 24th 2024For patients with biochemical recurrence of prostate cancer, PSMA PET imaging may facilitate a 12.8 percent lower incidence of prostate cancer mortality in contrast to the combination of CT and bone scan, according to long-term outcome estimates from a new decision-analytic modeling study.
Can Diffusion MRI Predict Patient Response to Neoadjuvant Chemotherapy for Breast Cancer?
October 23rd 2024A model emphasizing time-dependent diffusion MRI was 15 percent more effective than apparent diffusion coefficient (ADC) measurements at predicting pathologic complete response to neoadjuvant chemotherapy for women with breast cancer, according to new research.
